|
⚲
|
| Keyboard |
| Gibbs Thomas Edward
✚
|
|
|---|---|
| CIK # | 0001639012 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001639012] | |
| 4 | [0001639012] | |
| 5 | [0001639012] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| OptiNose Inc | |
| Gibbs Thomas Edward | |
| Vanda Pharmaceuticals Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
OptiNose Inc OPTN
Common Stock
|
2019-06-28 | Grant | 2,768 | $5.64 | 15,612 |
|
OptiNose Inc OPTN
Restricted Stock Units · derivative
|
2019-04-17 | Grant | 20,600 | $0.00 | |
|
OptiNose Inc OPTN
Common Stock
|
2019-03-07 | Sell | 2,000 | $8.24 | 16,480 |
|
OptiNose Inc OPTN
Stock Option (Right to Buy) · derivative
|
2019-02-28 | Grant | 82,500 | $0.00 | |
|
OptiNose Inc OPTN
Common Stock
|
2018-12-31 | Grant | 611 | $5.42 | 3,312 |
|
OptiNose Inc OPTN
Common Stock
|
2018-08-15 | Buy | 2,000 | $12.69 | 25,380 |
|
OptiNose Inc OPTN
Stock Option (Right to Buy) · derivative
|
2017-10-12 | Grant | 72,197 | $0.00 | |
|
Vanda Pharmaceuticals Inc VNDA
Employee Stock Option (Right to Buy) · derivative
|
2015-04-20 | Grant | 175,000 | $0.00 | |
|
Vanda Pharmaceuticals Inc VNDA
Restricted Stock Units · derivative
|
2015-04-20 | Grant | 60,000 | $0.00 |